All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @pepkits_official on TikTok · 204s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @pepkits_official's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Here are three things I wish I did better when I started my peptide company. One is a proper payment processor
  2. 0:07Right, you'll get approved for Stripe Square right away PayPal, you know plugins. They work great with all the basic website builders
  3. 0:16You are going to get shut down. You won't need a specialized processor and you will need WooCommerce WordPress to
  4. 0:25Get that working
  5. 0:27There's too much high risk associated with us and you won't need something that works better another one is having not enough stock
  6. 0:35right, so
  7. 0:37We did pre-orders when we started we got hit with
  8. 0:42Thousands of orders that we didn't have a material for it. And so we had to scramble and try to get orders
  9. 0:50fulfilled
  10. 0:52Three of the orders got ceased by customs. So now what?
  11. 0:57So now we're in the hole, right? So we're buying stuff. We don't have and
  12. 1:03The back orders are gonna get delayed even further and people don't like that
  13. 1:07so having a proper inventory to start is
  14. 1:12Top top three priority
  15. 1:15You can get away with you know with a minimal for now
  16. 1:19But once you start getting pallets of stuff in
  17. 1:22It's this game over if it gets these you are stuck and you're gonna spend your profits
  18. 1:28Getting the new stuff and the third item is going to be hiring a developer, right?
  19. 1:34Everyone loves to like customize their own website do all this crazy stuff
  20. 1:38But most times you're not gonna understand how WordPress works is complicated
  21. 1:44You're gonna have a lot of plugins you can have display information
  22. 1:47You're going to have a lot of problems that come up later on a lot of these payment processors that we have to use now
  23. 1:55require WooCommerce or WordPress plugins
  24. 1:59Obviously Shopify isn't gonna work
  25. 2:01They will show you down to so you basically have to end up having a custom website bill
  26. 2:07So we paid
  27. 2:09You know X amount to have a developer build the site and then we pay him a retainer of a thousand per month
  28. 2:17And then we're also going to be paying him for the SEO work, which is way over that
  29. 2:23Just to rank high on Google. So all that has to be taken account when you're trying to run a legitimate
  30. 2:30Petite research company you can't use Venmo. You can't use sell forever
  31. 2:35Your banks don't look at it weird, especially when you're gonna start doing what 10,000 $20,000 aces not gonna work
  32. 2:43So with all that being said
  33. 2:46You have to have a game plan and you have to have the funds available to make that
  34. 2:51Now we didn't have any funds. I'll give you that but we at least
  35. 2:56Thought about it, right? We got the pre-orders and we handled it
  36. 3:00We push as much as we could through square and stripe
  37. 3:04For as long as we could we got away with our Wix website
  38. 3:09terrible
  39. 3:10And now
  40. 3:12Now we're good. We have the baseline. So just some food for thought
  41. 3:18Everyone asking questions about where to start what to do. There's kind of a breakdown of that

Peptide 'ownership' tips: what TikTok sellers aren't telling you

Pepkits

TikTok creator

78.5K viewsWatch on TikTok

Quick answer

This video contains no clinical claims about peptide efficacy or safety. It is a vendor operations tutorial for selling research-labeled peptides, which are compounds not approved by the FDA for human use and increasingly subject to federal enforcement action, including the 2023 removal of BPC-157 and related peptides from the FDA's bulk compounding list. Consumers purchasing from vendors described in this video receive no manufacturing quality assurance, no physician oversight, and no legal protection under pharmaceutical frameworks.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Peptide 'ownership' tips: what TikTok sellers aren't telling you, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Peptide 'ownership' tips: what TikTok sellers aren't telling you is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Peptide 'ownership' tips: what TikTok sellers aren't telling you" from Pepkits. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: This video contains no clinical claims about peptide efficacy or safety.

The reason this review is not generic is the source wording and the canonical claim label "peptides 3 tips for new peptide owners researchpeptides peptideresear." In this clip, the useful excerpt is: "Here are three things I wish I did better when I started my peptide company." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The FDA removed BPC-157 and several related peptides from its bulk compounding list in 2023, increasing legal risk for both vendors and compounding pharmacies operating outside supervised frameworks.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

This video contains no clinical claims about peptide efficacy or safety.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • This video contains no clinical claims about peptide efficacy or safety. It is a vendor operations tutorial for selling research-labeled peptides, which are compounds not approved by the FDA for human use and increasingly subject to federal enforcement action, including the 2023 removal of BPC-157 and related peptides from the FDA's bulk compounding list. Consumers purchasing from vendors described in this video receive no manufacturing quality assurance, no physician oversight, and no legal protection under pharmaceutical frameworks.
  • A 2022 study by Rasmussen et al. in Drug Testing and Analysis found that a significant portion of 44 commercially tested peptide products had incorrect concentrations, mislabeling, or unidentified contaminants, meaning vendor business sophistication tells you nothing about product quality.
  • The FDA removed BPC-157 and several related peptides from its bulk compounding list in 2023, increasing legal risk for both vendors and compounding pharmacies operating outside supervised frameworks.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • A 2022 study by Rasmussen et al. in Drug Testing and Analysis found that a significant portion of 44 commercially tested peptide products had incorrect concentrations, mislabeling, or unidentified contaminants, meaning vendor business sophistication tells you nothing about product quality.
  • The FDA removed BPC-157 and several related peptides from its bulk compounding list in 2023, increasing legal risk for both vendors and compounding pharmacies operating outside supervised frameworks.
  • Research-use-only labeling is not a regulatory safe harbor. The FTC and FDA have both taken enforcement action against sellers who use this label while marketing to human consumers.
  • High-risk payment processor requirements are a signal that financial compliance systems flag this commerce as legally problematic, a fact the video reframes as a simple operational challenge.
  • Customs seizures of peptide shipments are not just shipping delays. They can constitute federal evidence of commerce in unapproved drug products under 21 U.S.C. 331.
  • Consumers buying from unregulated research peptide vendors have no recourse if a product is contaminated, misdosed, or causes harm, unlike patients using FDA-supervised compounding pharmacies or approved drugs.
  • Telehealth-supervised peptide therapy, where it is legal, involves physician evaluation, state-licensed pharmacy compounding, and documented informed consent, none of which exist in the vendor model described in this video.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @pepkits_official actually say?

This video is not about peptide science. It is a business tutorial for people who want to sell research peptides online. The creator of @pepkits_official walks through three operational lessons from running their own peptide company: get a high-risk payment processor because Stripe and Square will eventually shut you down, stock enough inventory before taking pre-orders, and hire a developer to build a custom WordPress or WooCommerce site because mainstream platforms like Shopify will also ban you.

They describe having orders "seized by customs," getting "shut down" by payment processors, and spending significant money on SEO to "rank high on Google." They frame this as advice for running a "legitimate peptide research company." That framing deserves scrutiny, which we will get to shortly.

Does the science back this up?

There is no science to fact-check here. This video makes zero claims about peptide biology, mechanism of action, clinical outcomes, or dosing. It is purely operational business advice directed at prospective vendors in what the FDA classifies as a legally ambiguous, largely unregulated commercial space.

What is worth flagging is the regulatory backdrop the creator skips over. Peptides like BPC-157, TB-500, CJC-1295, and ipamorelin are not FDA-approved drugs for human use. Many are sold under the "research chemical" label, which is a designation that creates legal cover for vendors but does not change the fact that these compounds are frequently purchased by humans for self-administration. The FDA has explicitly targeted certain peptides, removing BPC-157 and other compounds from the bulk compounding list in 2023, signaling increasing enforcement pressure on this market. The creator mentions customs seizures and payment processor bans as operational headaches, not as signs that the business model itself is legally precarious. That is a meaningful omission.

What did they get wrong (or right)?

On the business mechanics, the creator is largely accurate. High-risk payment processing is a real category. Vendors selling products associated with supplements, gray-market substances, or adult content do get terminated by Stripe and Square, often without much warning. This is documented in Stripe's own acceptable use policy, which prohibits "substances that present a risk to consumer safety" when sold outside normal regulatory channels.

The advice to use WooCommerce over Shopify is also practically accurate. Shopify has terminated accounts selling research peptides. WooCommerce, being self-hosted, gives vendors more control, though it does not make the underlying sales legal.

Where the creator gets things wrong, or at minimum incomplete, is the phrase "legitimate peptide research company." Selling research peptides online to anonymous buyers who are almost certainly using them on themselves is not the same as supplying verified research institutions. The "research use only" label is a legal gray area, not a compliance shield. Customs seizures, which they mention casually, can signal federal interest in the business. Framing these as purely logistical problems understates the legal exposure involved for both vendors and buyers.

What should you actually know?

If you are a consumer watching this video, the most important thing to understand is that the business being described exists in a legal and quality-control gray zone that directly affects your safety as a buyer.

Research peptides sold online are not subject to FDA manufacturing oversight. A 2022 study by Rasmussen et al. in the journal Drug Testing and Analysis tested 44 commercially available peptide products and found that a significant portion were mislabeled, contained incorrect concentrations, or included unidentified contaminants. You have no reliable way to verify what you are actually buying from vendors like the one described in this video.

Payment processor bans and customs seizures are not just operational headaches for sellers. They are indicators that regulatory and financial systems are flagging this commerce as high-risk. That risk does not disappear for the buyer just because the vendor found a workaround.

Telehealth platforms operating under physician oversight, state medical board regulation, and pharmacy compounding law are not the same as research peptide vendors optimizing their WooCommerce checkout. If you are interested in peptide therapy for a legitimate health goal, working with a licensed provider is the path that comes with accountability, real informed consent, and some recourse if something goes wrong.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Pepkits · TikTok creator

78.5K views on this video

3 tips for new peptide owners #researchpeptides #peptideresearch #smallbusiness

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about a 2022 study by rasmussen et al. in drug testing?

A 2022 study by Rasmussen et al. in Drug Testing and Analysis found that a significant portion of 44 commercially tested peptide products had incorrect concentrations, mislabeling, or unidentified contaminants, meaning vendor business sophistication tells you nothing about product quality.

What does the video say about the fda removed bpc-157?

The FDA removed BPC-157 and several related peptides from its bulk compounding list in 2023, increasing legal risk for both vendors and compounding pharmacies operating outside supervised frameworks.

What does the video say about research-use-only labeling?

Research-use-only labeling is not a regulatory safe harbor. The FTC and FDA have both taken enforcement action against sellers who use this label while marketing to human consumers.

What does the video say about high-risk payment processor requirements?

High-risk payment processor requirements are a signal that financial compliance systems flag this commerce as legally problematic, a fact the video reframes as a simple operational challenge.

What does the video say about customs seizures of peptide shipments?

Customs seizures of peptide shipments are not just shipping delays. They can constitute federal evidence of commerce in unapproved drug products under 21 U.S.C. 331.

What does the video say about consumers buying from unregulated research peptide vendors have no recourse?

Consumers buying from unregulated research peptide vendors have no recourse if a product is contaminated, misdosed, or causes harm, unlike patients using FDA-supervised compounding pharmacies or approved drugs.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Pepkits, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.